Question 1

What is Caris Life Sciences, Inc. Common Stock's WACC?

Accepted Answer

Caris Life Sciences, Inc. Common Stock (CAI) has a Weighted Average Cost of Capital (WACC) of 9.30%. This is calculated using a Cost of Equity of 8.85% (via CAPM with a beta of 1.00) and a pre-tax Cost of Debt of 15.00%, with an equity weight of 92.71% in the capital structure.

Question 2

Is Caris Life Sciences, Inc. Common Stock's WACC high or low?

Accepted Answer

Caris Life Sciences, Inc. Common Stock's WACC of 9.30% falls within the typical 8-12% range for mid-cap growth companies. WACC is used as the discount rate in DCF valuations — a lower WACC results in higher present values of future cash flows.

Question 3

How is Caris Life Sciences, Inc. Common Stock's WACC calculated?

Accepted Answer

Caris Life Sciences, Inc. Common Stock's WACC is calculated using the formula: WACC = (E/V × Re) + (D/V × Rd × (1-T)). The Cost of Equity (Re) of 8.85% is derived from the CAPM model using a beta of 1.00. The pre-tax Cost of Debt (Rd) is 15.00%. The capital structure is 92.71% equity and 7.29% debt.

Caris Life Sciences, Inc. Common Stock (CAI) — WACC 分析

WACC 构成

解读

Caris Life Sciences, Inc. Common Stock（CAI）WACC：9.30%

WACC计算器

Caris Life Sciences, Inc. Common Stock（CAI） WACC 解读

CAI 公司分析

CAI DCF 估值

继续做同行对比